News
25 Sep 2025
Glenmark Expands Oncology Portfolio with Exclusive Licensing of Hengrui’s HER2-Targeted ADC
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has entered into an exclusive license and collaboration…
